SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹211 Cr | ₹168 Cr | ₹69 Cr | ₹62 Cr | ₹28 Cr |
What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹211 Cr |
| Mar2024 | ₹168 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹62 Cr |
| Mar2017 | ₹28 Cr |
How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹211 Cr | 25.20 | |
| Mar2024 | ₹168 Cr | 145.53 | |
| Mar2023 | ₹69 Cr | 11.35 | |
| Mar2022 | ₹62 Cr | 122.16 | |
| Mar2017 | ₹28 Cr | - | |
Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,833.9 Cr | -3.8% | 28.1% | 12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.8% |
28.1% |
12.4% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses